News

During a live event, Kathleen A. Dorritie, MD, discussed updated outcomes from the GRIFFIN and PERSEUS clinical trials of ...
The approval follows October 2024's indication extension for daratumumab-VRd for newly diagnosed patients eligible for ASCT.